Introduction
============

Articular cartilage displays a limited capacity of self-renewal when suffered from trauma or degenerative disease. Consequently, stem cell-based tissue engineering is a promising method for cartilage repair ([@b1-mmr-16-06-8019]--[@b4-mmr-16-06-8019]). Mesenchymal stem cells (MSCs) are thought to be a promising cell source for their self-renewal and multi-lineage differentiation abilities, but the utility of MSCs has many unfavorable outcomes including low chondrogenic potential, vascularization and mineralization ([@b5-mmr-16-06-8019]--[@b8-mmr-16-06-8019]). The growth plate chondrocytes have the ability of continuous reproduction and differentiation. Thus it is long thought to be a cell source for cartilage repair strategies. But the growth plate chondrocytes are complicated, ranging from resting cells to proliferative, pre-hypertrophic and ultimately hypertrophic chondrocytes, the research about the growth plate remains elusive ([@b9-mmr-16-06-8019]).

Growth plate chondrocytes are believed to compose progenitors of different cell types ([@b10-mmr-16-06-8019],[@b11-mmr-16-06-8019]). By investigating the clonal relationship and lineage development of mesenchymal tissues in bone, Chan *et al* ([@b12-mmr-16-06-8019]) recently isolated a population of postnatal skeletal stem cells (SSCs) which are important for postnatal skeletal development. Unlike mesenchymal stem cells, SSCs seldom diffrentiate into adipocyte ([@b12-mmr-16-06-8019]). Similar research was also conducted by Worthley *et al* ([@b13-mmr-16-06-8019]), they found that bone morphogenetic protein (BMP) antagonist Gremlin 1 defines a population of osteochondroreticular (OCR) stem cells which mainly concentrated within the metaphysis of long bone and were also thought to be a population of SSCs. These cells could self-renew and generate osteoblasts, chondrocytes and reticular marrow stromal cells, but not adipocytes. They are important for bone development, bone remodeling and fracture repair ([@b13-mmr-16-06-8019]). Like hematopoietic stem cells, SSCs are heterogeneous and contain many lineage-restricted stem cells which lead to unreliable bone and cartilage formation ([@b14-mmr-16-06-8019]). So it is important to isolate purified subpopulation of SSCs which could differentiate along chondrogenic lineage steadily.

Cell surface marker based cell purification is a simple and efficacious cell sorting method. Two alternative markers comprising endoglin (CD105) and melanoma cell adhesion molecule (MCAM; CD146) have been identified on the cell surface of isolated populations of SSCs. These subpopulations of SSCs exhibited different biological characteristics. CD105, a type III receptor for the transforming growth factor β (TGF-β) superfamily, is known as a relatively specific marker for identifying mesenchymal stem cells ([@b15-mmr-16-06-8019]--[@b18-mmr-16-06-8019]). Several lines of evidence showed that CD105 is related to chondrogenic potential of human MSCs or adipose-derived stem cells (ASCs) ([@b4-mmr-16-06-8019],[@b19-mmr-16-06-8019]--[@b21-mmr-16-06-8019]). Chan *et al* ([@b12-mmr-16-06-8019]) found that CD105^+^ subpopulation represented a much more differentiated population of postnatal mouse SSCs compared with CD105^−^ cell population. CD105^+^ subpopulation is responsible for bone and cartilage regeneration and CD105 is a candidate marker for SSC isolation ([@b12-mmr-16-06-8019]). CD146, a cell adhesion molecule (CAM) that was originally identified as a tumor marker for melanoma (MCAM), has been studied as a putative mesenchymal stem cell marker in human umbilical cord perivascular cells (HUCPVCs) and bone marrow mesenchymal stromal cells (BMSCs) ([@b22-mmr-16-06-8019]--[@b24-mmr-16-06-8019]). Compared with CD146^−^ MSCs, the CD146^+^ MSCs exhibited a much stronger multi-lineage differentiation potential and capacity of maintaining stemness and phenotype after long cultivation ([@b24-mmr-16-06-8019],[@b25-mmr-16-06-8019]). There was also evidence showing that CD146 was a marker of cartilage-derived chondroprogenitor cells and CD146^+^ cartilage subpopulation exhibited greater therapeutic potential in cartilage repair and regeneration ([@b26-mmr-16-06-8019],[@b27-mmr-16-06-8019]). However, it remains to be ascertained whether CD105 and CD146 could offer improved SSCs isolation in the growth plate.

Based on the aforementioned studies, it was hypothesized that purified SSCs may represent an improved alternative cell source compared with unsorted growth plate chondrocytes and ASCs for cartilage repair and tissue engineering. In the present study, we identified the existence and distribution of CD105^+^ SSCs and CD146^+^ SSCs in the growth plate. We then purified SSCs using CD105 and CD146 cell surface markers via magnetic activated cell sorting (MACS) method. Finally, we compared the colony-forming efficiency (CFE) and multi-lineage differentiation capacity of unsorted growth plate chondrocytes, CD105^+^ SSCs, CD146^+^ SSCs and ASCs *in vitro*.

Materials and methods
=====================

### Isolation and culture of growth plate chondrocytes and ASCs

Growth plate chondrocytes were obtained from 1-week-old Sprague-Dawley rats (Experimental Animal Center of Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China). All animal procedures were approved by the Ethics Committee on Animal Experimentation of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).

Growth plate in distal femurs and proximal tibias of SD rats were isolated and subtly cut into pieces. After several rinses in phosphate-buffered saline (PBS), the pieces were subsequently digested with 0.25% trypsin solution (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 20 min and 0.1% solution of collagenase type II (Invitrogen; Life Technologies, Carlsbad, CA, USA) at 37°C over night. The cells were then harvested and cultured in Dulbecco\'s modified Eagles medium/Ham\'s F-12 (DMEM/F-12) supplemented with 10% fetal bovine serum (FBS) (both from Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and antibiotics \[(100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate (Gibco; Thermo Fisher Scientific, Inc.)\].

ASCs were isolated from 8-weeks-old Sprague-Dawley rats (Experimental Animal Center of Tongji Hospital). Adipose tissue was digested with collagenase type I (Invitrogen; Life Technologies) for 1 h at 37°C. The cells were then harvested and cultured in the DMEM/F-12 (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% FBS and antibiotics \[(100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate (Gibco; Thermo Fisher Scientific, Inc.)\]. When reaching 90% confluence, cells were passaged to obtain sufficient number of ASCs.

### Flow cytometry analysis of stem cell surface markers on the growth plate chondrocytes

Chondrocytes (1×10^6)^ from growth plate (passage 1) were washed in PBS and incubated with corresponding primary antibodies for one hour at 4°C. Primary antibodies used here were conjugated antibodies specific for CD44-FITC (dilution 1:100, \#550974; BD Biosciences, San Diego, CA, USA), CD29-PE (dilution 1:80, \#48-0291; eBiosciences; Thermo Fisher Scientific, Inc.), CD34-PE (dilution 1:100; \#sc-74499 PE; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), CD45-PE (dilution 1:80, \#12-0461; eBiosciences; Thermo Fisher Scientific, Inc.) and unconjugated antibodies for CD105 (dilution 1:100, \#ab11414) and CD146 (dilution 1:80, \#ab75769) (both from Abcam, Cambridge, MA, USA). After washing with PBS, cells stained with CD105 and CD146 were incubated with anti-mouse FITC-conjugated secondary antibody (dilution 1:500, \#A0568; Beyotime Institute of Biotechnology, Guangzhou, China) or Alexa Fluor 594 donkey anti-rabbit IgG (dilution 1:500, \#A-21207; Invitrogen; Life Technologies) for 30 min at 4°C. The cells were washed twice and then re-suspended in 200 µl PBS for the flow cytometry analysis (FACSort; BD Biosciences).

### Immunohistochemistry (IHC) analysis of CD146 and CD105 expression in the growth plate

Proximal tibias of 1-week-old SD rats were isolated and fixed with 4% formaldehyde. The samples were decalcificated with 12.5% EDTA solution, dehydrated, embedded into paraffin wax and sectioned at 5 mm thickness. Primary mouse anti-CD105 antibody (dilution 1:100) and rabbit anti-CD146 antibody (dilution 1:250) (both from Abcam) were used for immune labeling according to manufacturer\'s instructions. Then sections were incubated with biotinylated goat anti-mouse or goat anti-rabbit secondary antibodies (\#BA1001 or \#BA1003, dilution 1:2,000; Boster Biological Technology, Wuhan, China) at RT for 30 min. Reactivity was detected with a diaminobenzidine tetrahydrochloride (DAB) substrate kit (Beyotime Institute of Biotechnology), with hematoxylin as the counterstain. Images were captured by microscopy (FV500; Olympus Corporation, Tokyo, Japan).

### Cell sorting by MACS

About 5×10^6^ growth plate chondrocytes were harvested for magnetic activated cell sorting (Miltenyi, Teterow, Germany) according to manufacturer\'s instructions. Briefly, single-cell suspensions were incubated with mouse anti-CD105 antibody (dilution 1:100) or rabbit anti-CD146 antibody (dilution 1:80) (both from Abcam) for 30 min at 37°C. After centrifugated at 300 × g for 10 min and washed by PBS twice, the cells were then incubated with anti-rabbit IgG microbeads or anti-mouse IgG microbeads for 15 min at 37°C. The cells were then washed and resuspended with washing buffer and added into the MS column, the CD146^+^ SSCs and CD105^+^ SSCs were obtained following the instructions. The sorted cells were cultured in growth medium to obtain sufficient quantities for further research.

### Immunofluorescence assay

To confirm the expression of CD105 and CD146 in sorted cells, immunofluorescence staining was performed. Cells were grown to sub confluence on coverslips in 12-wells plate. Cells were then fixed with 4% paraformaldehyde for 20 min at room temperature and washed 3 times with PBS. After that, the cells were incubated with 0.1% Triton X-100 for 15 min at room temperature (RT) and blocked with 1% bovine serum albumin (Biosharp, Hefei, China) for 1 h at room temperature. Then the cells were incubated with mouse anti-CD105 antibody (dilution 1:100) or rabbit anti-CD146 antibody (dilution 1:80) (both from Abcam) overnight at 4°C. After washing with PBS, cells stained with CD105 or CD146 were incubated with anti-mouse FITC-conjugated secondary antibody (dilution 1:500, \#A0568; Beyotime Institute of Biotechnology) or Alexa Fluor 594 donkey anti-rabbit IgG (dilusion 1:1,000, \#A-21207; Invitrogen; Life Technologies) for 1 h at room temperature. The nuclei were then labeled with DAPI (50 µg/ml; Sigma-Aldrich; Merck KGaA) for 5 min. Fluorescence images were captured by fluorescence microscopy (FV500; Olympus Corporation).

### CFE assay

The proliferative induction capability of the cells was evaluated by CFE analysis. Briefly, 100 cells were seeded and cultured in 60-mm dishes. Two weeks later, colonies formed from single cell were fixed in 4% paraformaldehyde for 20 min at RT. After washing with PBS for three times, Giemsa (\#ab150670; Abcam) staining was performed according to manufacturer\'s instructions. Colonies with \>50 cells were counted and recorded.

### Multi-lineage differentiation assays

Cells at passage 3 were initially seeded in a 6-well plate at the density of 3×10^4^ cells/cm^2^. When they reached 90% confluence, cells were washed with PBS and transferred to commercially available adipogenic or osteogenic medium (\#RASMD-90031 or \#RASMD-90021; Cyagen Biosciences Inc., Santa Clara, CA, USA). After 3 weeks, cells were fixed by 4% paraformaldehyde and washed 3 times with PBS. For adipogenic assay, cells were incubated with Oil red O (Cyagen Biosciences Inc.) for 30 min to detect the intra-cellular lipid droplets. For quantitative evaluation, dye content was extracted using isopropanol and the absorbance at a wavelength of 540 nm was detected. For osteogenic assay, cells were stained with Alizarin Red (Cyagen Biosciences Inc.) for 10 min at room temperature.

A pellet culture system was used for chondrogenic differentiation. Briefly, 1×10^6^ cells were placed and centrifugated at 300 × g for 15 min in a 15 ml polypropylene tube to form a pellet. Then pellets were cultured in the chondrogenic medium (\#RASMD-90041; Cyagen Biosciences Inc.), which was changed every 3 days. After induction for 3 weeks, the cell pellets were fixed by 4% paraformaldehyde, dehydrated and then embedded into paraffin wax. Tissue blocks were cut into 5 mm sections and were placed on slides and dried overnight at 37°C. Chondrogenic differentiation was finally assessed by Alician blue staining (Cyagen Biosciences Inc.) and IHC using antibodies against aggrecan (dilution 1:50, \#ab36861) and type II collagen (dilution 1:100, \#ab185430) (both from Abcam) according to the manufacturer\'s protocols.

### Real-time quantitative polymerase chain reaction (RT-qPCR) analysis

Total mRNA was extracted using TRIzol reagent (Invitrogen; Life Technologies) following the manufacturer\'s instructions. Complementary DNA (cDNA) was obtained from total RNA using ReverTra Ace qPCR RT kit (Toyobo Co., Ltd., Osaka, Japan) according to the manufacturer\'s protocols. Then the cDNA was amplified by SYBR Green Real-Time PCR Master Mix (Toyobo Co., Ltd.) with following cycling conditions: 30 sec of polymerase activation at 95°C, followed by 40 cycles of 95°C for 5 sec and 60°C for 30 sec. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control. The relative expression levels of each gene were calculated using the comparative 2^−ΔΔCt^ method ([@b28-mmr-16-06-8019]). Sequences of primers for interested genes are listed in [Table I](#tI-mmr-16-06-8019){ref-type="table"}.

### Statistical analyses

All experiments were performed in triplicate, and one representative set was chosen to be shown. All data are presented as mean and standard deviation (SD) and analyzed with GraphPad Prism 6.0. The significance of difference was determined using the Student\'s t-test and analysis of variance (ANOVA); differences with P\<0.05 were considered significant.

Results
=======

### Surface antigen profiles

Flow cytometry analyses were performed to assess the phenotype of the growth plate chondrocytes. Results showed that 42.73% of the cells were positive for CD146 and 20.6% of the cells were positive for CD105. Meanwhile, growth plate chondrocytes were negative for the hematopoietic markers (CD34 and CD45) and MSC-associated surface markers (CD29 and CD44) ([Fig. 1A](#f1-mmr-16-06-8019){ref-type="fig"}).

### Distribution of CD146^+^ SSCs and CD105^+^ SSCs in growth plate

The growth plate was divided into resting zone, proliferative zone, prehypertrophic and hypertrophic zone. We then identified the distribution of CD146^+^ SSCs and CD105^+^ SSCs in growth plate using IHC. As shown in [Fig. 1B and C](#f1-mmr-16-06-8019){ref-type="fig"}, CD146^+^ SSCs mainly located at the resting zone, partly located at the proliferating zone of the growth plate, while the CD105^+^ SSCs mainly located at the resting zone and the hypertrophic zone of growth plate.

### Isolation and cell morphology of CD146^+^ SSCs and CD105^+^ SSCs

We then isolated CD146^+^ SSCs and CD105^+^ SSCs using MACS method. Immunofluorescence staining of the isolated cells confirmed that the CD146^+^ SSCs and CD105^+^ SSCs were successfully isolated and cultured respectively ([Fig. 2A](#f2-mmr-16-06-8019){ref-type="fig"}). For cell morphology ([Fig. 2B](#f2-mmr-16-06-8019){ref-type="fig"}), unsorted growth plate chondrocytes generally showed heterogeneous populations containing triangle and fibroblast-like cells. Isolated CD146^+^ SSCs and CD105^+^ SSCs cells were more fibroblast-like. Obvious differences in morphology were noted between unsorted and MACS-sorted CD146^+^ and CD105^+^ subpopulations.

### The CFE of CD146^+^ SSCs and CD105^+^ SSCs compared with unsorted cells and ASCs

After 14 days of incubation, colony-forming unites were observed in all four groups. The unsorted growth plate chondrocytes yielded the highest number of colonies followed by CD146^+^ SSCs and CD105^+^ SSCs. The CFE of CD146^+^ SSCs was 2.2 fold stronger than CD105^+^ SSCs. The ASCs showed a much weaker CFE compared with the unsorted growth plate chondrocytes, CD105^+^ SSCs and CD146^+^ SSCs ([Fig. 3](#f3-mmr-16-06-8019){ref-type="fig"}).

### Adipogenic differentiation potential of CD146^+^ SSCs and CD105^+^ SSCs compared with unsorted cells and ASCs

The adipogenic differentiation capacity of CD146^+^ SSCs and CD105^+^ SSCs was measured and compared with unsorted cells and ASCs. After 21 days of adipogenic induction, a large amount of oil-red positive lipid droplets were found in unsorted cells and ASCs, while little was detected in CD105^+^ SSCs or CD146^+^ SSCs ([Fig. 4A and B](#f4-mmr-16-06-8019){ref-type="fig"}).

RT-qPCR showed similar results. After 2 week of adipogenic induction, CD105^+^ and CD146^+^ enriched populations exhibited decreased peroxisome proliferators-activated receptor-γ (PPAR-γ), lipoprteinlipase (LPL) and adipocyte fatty acid-binding protein 2 (AP2) expression compared with unsorted cells and ASCs. The PPAR-γ expression of unsorted cells was 9-fold over the CD105^+^ SSCs, 24-fold over the CD146^+^ SSCs, and 2-fold over ASCs. Similar trends were also observed in the LPL and AP2 expression ([Fig. 4C](#f4-mmr-16-06-8019){ref-type="fig"}). These results suggested that CD105^+^ SSCs and CD146^+^ SSCs could hardly differentiate into adipocytes.

### Osteogenic differentiation potential of CD146^+^ SSCs and CD105^+^ SSCs compared with unsorted cells and ASCs

To assess the osteogenic differentiation potential of CD146^+^ SSCs and CD105^+^ SSCs, cells were cultured in osteogenic medium for 21 days. All four groups showed formation of red calcium deposits. The CD146^+^ SSCs and CD105^+^ SSCs exhibited similar amounts of calcium-containing mineralized nodules compared with unsorted cells and ASCs ([Fig. 5A](#f5-mmr-16-06-8019){ref-type="fig"}).

Total RNA was extracted from the cells respectively after cultivation in osteogenic medium for 2 weeks. RT-qPCR was then conducted to assess the expression of osteogenic related genes including runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP) and osteopontin (OPN). After 2 weeks of osteogenic induction, the CD105^+^ SSCs showed higher expression of RUNX2, ALP and OPN than the CD146^+^ SSCs. The RUNX2, ALP and OPN levels in CD105^+^ SSCs and CD146^+^ SSCs were higher than unsorted cells and ASCs ([Fig. 5B](#f5-mmr-16-06-8019){ref-type="fig"}).

### Chondrogenic differentiation potential of CD146^+^ and CD105^+^ SSCs compared with unsorted cells and ASCs

To assess the chondrogenic differentiation potential of CD146^+^ SSCs and CD105^+^ SSCs, micromass pellets were cultured in chondrogenic medium for 21 days. Alician blue staining was performed to characterize the proteoglycan formation. Differentiated chondrocytes surface markers, aggrecan and type II collagen, were assessed using IHC. Alician blue staining revealed a higher content of proteoglycan in CD146^+^ pellets. Consistently, CD146^+^ pellets showed much higher contents of aggrecan and type II collagen compared with pellets in other three groups ([Fig. 6A](#f6-mmr-16-06-8019){ref-type="fig"}).

After cultivation in chondrogenic medium for 2 weeks, total RNA was extracted and subjected to RT-qPCR. The mRNA levels of chondrogenic markers including SRY-box containing gene 9 (SOX9), type II collagen and aggrecan were evaluated. As shown in [Fig. 6B](#f6-mmr-16-06-8019){ref-type="fig"}, CD146^+^ SSCs exhibited higher mRNA level of SOX9 compaired with unsorted cells, CD105^+^ SSCs and ASCs. Furthermore, extraordinarily high levels of aggrecan and type II collagen were observed in the CD146^+^ SSCs. The aggrecan expression level in CD146^+^ SSCs was 36-fold over unsorted cells, 6-fold over CD105^+^ SSCs, and 91.4-fold over ASCs. Consistently, the expression level of type II collegen in CD146^+^ SSCs was 353-fold over unsorted cells, 34-fold over CD105^+^ SSCs and 548-fold over ASCs. These results suggested that the CD146^+^ SSCs exhibited a strong and steady chondrogenic differentiation capacity *in vitro*.

Discussion
==========

The mesenchymal stem cells represent a powerful tool for cartilage tissue regeneration, but their utility is limited by low chondrogenic potential, vascularization and mineralization ([@b29-mmr-16-06-8019]). So it is important to isolate a stem cell which could differentiate strictly along chondrogenic lineage. The regenerative capacity of bone indicates the presence of skeletal stem cell in bone. However, while this regenerative ability has long been recognized, the identity of the responsible cell population *in vivo* has only recently been confirmed. Recent researches demonstrated the existence of SSCs at the end of long bones. SSCs could self-renew and generate bone and cartilage, but not adipocytes ([@b12-mmr-16-06-8019]). Like hematopoietic stem cells, SSCs are diverse, with distinct cell-surface marker profiles and distinct fates ([@b14-mmr-16-06-8019]). Theoretically, SSCs with appropriate cell surface markers could offer an ideal cell source for cartilage tissue engineering. In the present study, we successfully isolated SSCs from growth plate using cell surface markers CD105 and CD146. These subpopulations of SSCs could self-renew and differentiate into osteoblasts and chondrocytes but not adipocytes.

The growth plate contains three zones that include chondrocytes at different stages of differentiation ([@b30-mmr-16-06-8019]--[@b32-mmr-16-06-8019]). The zone closest to the epiphysis is termed the resting zone. The resting zone is thought to contain chondrocytes that serve as progenitor cells, which can generate new clones of rapidly proliferating chondrocytes ([@b9-mmr-16-06-8019],[@b33-mmr-16-06-8019]). In the present study, flow cytometry showed that the growth plate chondrocytes are positive for CD105 and CD146. IHC revealed that the CD105^+^ SSCs mainly located in the resting zone and hypertrophic zone while the CD146^+^ SSCs mainly located in the resting zone and proliferating zone. Many researches demonstrated the existence of CD146^+^ subpopulation in osteoarthritis cartilage chondrocytes and indicated that CD146 is a chondroprogenitor-associated marker ([@b34-mmr-16-06-8019],[@b35-mmr-16-06-8019]). CD146 was reported to be involved in cell-cell, cell-matrix interactions and cell migration ([@b36-mmr-16-06-8019]--[@b38-mmr-16-06-8019]). There are evidences identifying that CD146^+^ subpopulation has a high migration abilitiy and is responsible for tumor metastasis as well as tissue repair ([@b39-mmr-16-06-8019],[@b40-mmr-16-06-8019]). A previous study suggested that CD146 was also expressed in bone marrow derived mesenchymal stem cells and had been used for the isolation of this cell population ([@b41-mmr-16-06-8019]). Thus we postulated that SSCs mainly located in the resting zone of the growth plate and could reproduce and migrate to the place where needed.

SSCs were thought to contribute to the postnatal growth of the long bone and bone fracture repair ([@b42-mmr-16-06-8019]--[@b44-mmr-16-06-8019]). SSCs contain different types of progenitors, which are responsible for bone and cartilage formation, but not for adipose tissue or muscle tissue formation. The CD105 was demonstrated as a marker of SSCs ([@b12-mmr-16-06-8019]). In this study, we found that the CD146^+^ cells exhibited high osteogenic, chondrogenic differentiation capacity and extremely low adipogeneic capacity *in vitro*, suggesting that CD146^+^ cells are also a subset of SSCs. Furthermore, results of RT-qPCR showed that the expression of chondrogenic related genes, such as aggrecan and type II collagen, in the CD146^+^ SSCs were extraordinarily higher than CD105^+^ SSCs and ASCs. These results were corroborated by IHC. Taken together, our data implicated that the CD146^+^ subpopulation represents a subset of SSCs which is much differentiated and prone to differentiate into chondrocytes. The CD146^+^ subpopulation is a chondrogenic lineage restricted stem cells, or precartilaginous stem cell. It has the ability of efficiently differentiating into chondrocytes with extensive extracellular matrix (ECM) formation.

Both CD105^+^ and CD146^+^ SSCs were discussed in the present study. But there are also evidences showing that CD105^+^ subpopulation is responsible for endochondral ossification and has lost the chondrogenesis potential ([@b6-mmr-16-06-8019],[@b45-mmr-16-06-8019]). Consistently, we found that CD105^+^ subpopulation expressed higher levels of osteogenetic genes. Taking into account that CD146^+^ MSCs derived from bone marrow were prone to differentiate into chondrocytes ([@b46-mmr-16-06-8019]) and that CD146^+^ chondroprogenitor cells with multi-lineage differentiation abilities were found in articular cartilage ([@b35-mmr-16-06-8019]), CD146 might be regarded as a marker for chondroprogenitor subpopulation. Our data also revealed that CD146^+^ SSCs isolated from the growth plate exhibited superior chondrogenic differentiation capacity compared CD105^+^ SSCs. Taken together, these data suggest that CD105^+^ subpopulations and CD146^+^ subpopulations may have different cell fate and that CD105^+^ SSCs may be used to enhance endochondral ossification while CD146^+^ SSCs are more appropriate as a stem cell source for cartilage repair.

The proliferative capacity of stem cells is important with regard to their application in cell therapy. In the present study, the proliferative capacity of the CD105^+^ and the CD146^+^ subpopulations were compared with that of unsorted cells and ASCs using CFE assay. Of note, it was identified that the unsorted growth plate chondrocytes exhibited the highest CFE *in vitro*. Chan *et al* ([@b12-mmr-16-06-8019]) suggested that the SSCs are diverse, similar to the diverse hematopoietic progenitor cells that generate various differentiated blood cells. This may imply that the unsorted growth plate chondrocytes contain subpopulations which are more primitive and have higher capacity of self-renewal. However, the oil-red staining results showed that they were prone to differentiate into adipocytes. The results of RT-qPCR identified that the unsorted growth plate chondrocytes expressed much higher level of adipogenic differentiation related genes, including PPAR-γ, LPL and AP2. PPAR-γ is a key transcriptional regulator of adipogenesis. Wang *et al* ([@b47-mmr-16-06-8019]) found that PPAR-γ is expressed in growth plate chondrocytes and PPAR-γ is able to promote adipogenic differentiation in growth plate chondrocytes, while negatively regulate chondrogenic differentiation and terminal differentiation.

In the present study, we isolated purified subpopulations of SSCs using MACS method. We found that both CD105^+^ and CD146^+^ subpopulations had a higher CFE than ASCs. Moreover, compared with the CD105^+^ subpopulation, the CFE of the CD146^+^ subpopulation was much higher. Consistently, CD146^+^ subpopulations mainly located in the resting zone and proliferative zone of the growth plate, which suggested that CD146^+^ subpopulations are progenitor cells which can generate new clones of rapidly proliferating chondrocytes.

ASCs are attractive stem cell source for tissue engineering ([@b48-mmr-16-06-8019]--[@b50-mmr-16-06-8019]). These cells can be obtained by simple liposuction and had ability of multi-lineage differentiation. Under appropriate culture conditions, they can differentiate along osteogenic lineage ([@b50-mmr-16-06-8019]--[@b52-mmr-16-06-8019]), chondrogenic lineage ([@b53-mmr-16-06-8019]), and adipogenic lineage. Our results showed that CD146^+^ SSCs exhibited higher colony forming capacity compared compared with ASCs. Most importantly, the CD146^+^ SSCs showed a steady and high chondrogenic related gene expression and ECM formation *in vitro* after a long period of cultivation. These results also implied that compared with ASCs the CD146^+^ SSCs could be a much more appropriate stem cell source for cartilage tissue engineering.

In summary, we identified the existence of SSCs in the growth plate and the CD105^+^ and the CD146^+^ subpopulations represented subsets of SSCs which could generate chondrocytes and osteocytes, but not adipocytes. Compared with CD105^+^ subpopulations and ASCs, the CD146^+^ subpopulation exhibited higher colony forming capacity and continuous high chondrogenic differentiation capacity *in vitro*. Thus we propose that CD146^+^ subpopulation is chondrogenic lineage restricted SSCs and it could provide cell candidates for cell-based cartilage regeneration.

This work was supported by grants from the National Natural Science Foundation of China (no. 81371915 and 81572094).

![Surface markers of growth plate chondrocytes and distribution of CD146^+^ SSCs and CD105^+^ SSCs in the growth plate. (A) Flow cytometry analysis of growth plate chondrocytes. The growth plate chondrocytes were positive for CD105 and CD146 while negative for CD34, CD45, CD29 and CD44. (B) Immunohistochemical staining of CD105^+^ SSCs and CD146^+^ SSCs. The CD105^+^ SSCs mainly located at the resting zone and the hypertrophy zone of growth plate. (C) The CD146^+^ SSCs mainly located at the resting zone and the proliferating zone. Different zones of the growth plate were marked. Scar bar, 100 µm. SSCs, skeletal stem cells; R, resting zone; P, proliferative zone; PH+H, prehypertrophic and hypertrophic zone; CD, cluster of differentiation.](MMR-16-06-8019-g00){#f1-mmr-16-06-8019}

![Cell morphology of isolated stem cells. (A) Immunofluorescence staining was performed on CD105^+^ SSCs and CD146^+^ SSCs, the nuclei were counterstained with DAPI. (B) Morphology of unsorted growth plate cells, CD105^+^ SSCs, CD146^+^ SSCs and ASCs. Scar bar, 100 µm. ASCs, adipose-derived stem cells; SSCs, skeletal stem cells; CD, cluster of differentiation.](MMR-16-06-8019-g01){#f2-mmr-16-06-8019}

![Comparison of cell proliferation capacity. (A) The CFE of unsorted growth plate cells, CD105^+^ SSCs, CD146^+^ SSCs and ASCs was detected respectively. (B) Numbers of colony unites were counted. All data are from 3 independent experiments and are presented as means ± SD. \*P\<0.05 vs. unsorted cells; ^\#^P\<0.05 vs. ASCs; ^α^P\<0.05 vs. CD105^+^ SSCs. CFE, colony-forming efficiency; ASCs, adipose-derived stem cells; SSCs, skeletal stem cells; CD, cluster of differentiation.](MMR-16-06-8019-g02){#f3-mmr-16-06-8019}

![Comparison of adipogenic differentiation potential. (A) Oil Red O staining of unsorted cells, CD105^+^ SSCs, CD146^+^ SSCs and ASCs. Scar bar, 200 µm. (B) Quantitative measurement of lipid droplets in all four groups. (C) The mRNA levels of PPAR-γ, LPL and AP2 were detected using reverse transcription-quantitative polymerase chain reaction. All data are from 3 independent experiments and are presented as means ± SD. \*P\<0.05 vs. unsorted cells; ^\#^P\<0.05 vs. ASCs; ^α^P\<0.05 vs. CD105^+^ SSCs. PPAR-γ, peroxisome proliferators-activated receptor-γ; LPL, lipoprteinlipase; AP2, adipocyte fatty acid-binding protein 2; ASCs, adipose-derived stem cells; SSCs, skeletal stem cells; CD, cluster of differentiation.](MMR-16-06-8019-g03){#f4-mmr-16-06-8019}

![Comparison of osteogenic differentiation potential. (A) Alizarin red staining of unsorted cells, CD105^+^ SSCs, CD146^+^ SSCs and ASCs. Scar bar, 100 µm. (B) The mRNA levels of Runx2, ALP and OPN were detected using reverse transcription-quantitative polymerase chain reaction. All data are from 3 independent experiments and are presented as means ± SD. \*P\<0.05 vs. unsorted cells; ^\#^P\<0.05 vs. ASCs, ^α^P\<0.05 vs. CD105^+^ SSCs. RUNX2, runt-related transcription factor 2; ALP, alkaline phosphatase; OPN, osteopontin; ASCs, adipose-derived stem cells; SSCs, skeletal stem cells; CD, cluster of differentiation.](MMR-16-06-8019-g04){#f5-mmr-16-06-8019}

![Comparison of chondrogenic differentiation potential. (A) Pellets derived from unsorted cells, CD105^+^ SSCs, CD146^+^ SSCs and ASCs were stained with Alician blue or immunohistochemically stained with aggrecan or type II collagen respectively. Scar bar, 100 µm. (B) The mRNA levels of SOX9, aggrecan and type II collagen were detected using RT-qPCR. All data are from 3 independent experiments and are presented as means ± SD. \*P\<0.05 vs. unsorted cells; ^\#^P\<0.05 vs. ASCs; ^α^P\<0.05 vs. CD105^+^ SSCs. SOX9, SRY-box containing gene 9; AGG, aggrecan; COL2, type II collegen; ASCs, adipose-derived stem cells; SSCs, skeletal stem cells.](MMR-16-06-8019-g05){#f6-mmr-16-06-8019}

###### 

Primers used for RT-qPCR.

  Gene       Accession no.   Primer sequence (5′-3′)
  ---------- --------------- ----------------------------
  PPAR-γ     NM_001145366    F: CGGTTGATTTCTCCAGCATT
                             R: TCGCACTTTGGTATTCTTGG
  LPL        NM_012598       F: AACATTGGAGAAGCCATTCG
                             R: TTCATTCAGCAGGGAGTCAA
  AP2        NM_053365       F: ATGTGTCATGAAAGGCGTGA
                             R: AAACCACCAAATCCCATCAA
  RUNX2      NM_001278483    F: CTACTCTGCCGAGCTACGAAAT
                             R: TCTGTCTGTGCCTTCTTGGTTC
  ALP        NM_013059       F: CCTGGACCTCATCAGCATTT
                             R: AGGGAAGGGTCAGTCAGGTT
  OPN        NM_012881       F: CAAGGACCAACTACAACCA
                             R: GGAGACAGGAGGCAAGG
  SOX9       NM_080403       F: GTGGGAGCGACAACTTTACC
                             R: GCGAGCACTTAGCAGAGGC
  Aggrecan   NM_022190       F: CAAACAGCAGAAACAGCCAAGT
                             R: GAAGGCATAAGCATGTGAAAGTG
  COL2       NM_012929       F: CACCCAGAGTGGAAGAGCG
                             R: TCAGTGGACAGTAGACGGAGGA

F, forward; R, reverse; PPAR-γ, peroxisome proliferators-activated receptor-γ; LPL, lipoprteinlipase; AP2, adipocyte fatty acid-binding protein 2; RUNX2, runt-related transcription factor 2; ALP, alkaline phosphatase; OPN, osteopontin; SOX9, sex-determining region Y-box containing gene 9; AGG, aggrecan; COL2, type II collegen; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.
